Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-25-000842
Filing Date
2025-06-09
Accepted
2025-06-09 16:08:41
Documents
1
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 e664611_4-skerjanec.html 4  
1 e664611_4-skerjanec.xml 4 3859
  Complete submission text file 0001193805-25-000842.txt   5432
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Issuer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AVIDITY BIOSCIENCES, INC. 10578 SCIENCE CENTER DRIVE, SUITE 125 SAN DIEGO CA 92121
Business Address
Skerjanec Simona (Reporting) CIK: 0002022163 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36201 | Film No.: 251034145